After launching a vision-loss awareness effort last month, Allergan has teamed up with its first celebrity spokesman: Common.

Johnson & Johnson, pushing empathy as a tool to connect with consumers, is using product-paired apps as a way to do well by doing good.

Novartis is taking its digital efforts up a notch with new tools designed to help multiple sclerosis patients understand their illness.

The FDA’s promotional enforcement squad wasn’t very active in 2016—until December, that is. This month, they've cited six drugmakers, more than half the…

Multiple sclerosis drugmakers are in a fix: These days, the U.S. market isn’t delivering the kind of growth that had been fueling big increases in sales.…

Merck & Co.’s U.S. biosimilars are still in the clinic--but the pharma giant wants to prepare the ground for their arrival.

Actress and singer Queen Latifah recently took her passion for heart disease awareness live on social media, leading a “Rise Above Heart Failure” panel…

Cancer drug websites load up on numbers about benefits, but tread lightly on side effects, an FDA study found. It’s the latest to flag weaknesses in cancer…

Digital and Social Media